Related Experiment Videos

Variation in the matrix metalloproteinase-3, -7, -12 and -13 genes is associated with functional status in rheumatoid

S Ye1, N Patodi, K Walker-Bone

  • 1Human Genetics Division, School of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK. shu.Ye@soton.ac.uk

International Journal of Immunogenetics
|March 22, 2007
PubMed

Insights

Genetic variations in matrix metalloproteinase (MMP) genes, specifically MMP3, MMP7, MMP12, and MMP13, are linked to functional disability in rheumatoid arthritis patients. These MMP genotypes may influence disease severity and patient outcomes.

Area of Science:

  • Rheumatology and Genetics
  • Molecular Biology and Disease Mechanisms

Background:

  • Matrix metalloproteinases (MMPs) are implicated in the pathogenesis of rheumatoid arthritis (RA).
  • Genetic polymorphisms in MMP genes may influence individual susceptibility and disease progression in RA.

Purpose of the Study:

  • To investigate the association between variations in MMP gene polymorphisms and functional disability in patients with rheumatoid arthritis.
  • To determine if specific MMP genotypes correlate with disease severity as assessed by clinical indices.

Main Methods:

  • Genotyping of rheumatoid arthritis patients for specific polymorphisms in MMP1, MMP3, MMP7, MMP12, and MMP13 genes.
  • Assessment of functional disability using the Steinbrocker index and Health Assessment Questionnaire (HAQ) score.
  • Statistical analysis to identify correlations between MMP genotypes and functional status, adjusting for clinical covariates.

Main Results:

  • A significant association was found between the MMP13-77 A > G polymorphism and the Steinbrocker index, with the A/A genotype linked to higher disability scores (P = 0.003 after adjustment).
  • Relationships were also observed between functional status and polymorphisms in MMP3 (5A > 6A), MMP7 (181G > A), and MMP12 (82A > G).
  • No significant associations were detected for MMP1 (1607 1G > 2G) or MMP7 (153C > T) polymorphisms with functional disability measures.

Conclusions:

  • MMP3, MMP7, MMP12, and MMP13 genotypes may contribute to determining the functional status of rheumatoid arthritis patients.
  • These genetic variations could serve as potential biomarkers for predicting disease progression and functional outcomes in RA.
  • Further research is warranted to elucidate the precise mechanisms by which these MMP gene variations impact rheumatoid arthritis pathophysiology.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...